CD34 and systemic sclerosis: Indeed, we have previously shown that clinically involved skin of patients with SSc displays a progressive impairment in the dermal network of TCs/CD34+ stromal cells, starting from the early cutaneous disease stage up to almost their complete loss in the advanced stage [31,32].